Please use this identifier to cite or link to this item: http://repository.aaup.edu/jspui/handle/123456789/3545
Full metadata record
DC FieldValueLanguage
dc.contributor.authorQalalwah, Mohammed Fathi$AAUP$Palestinian-
dc.date.accessioned2025-09-07T07:18:13Z-
dc.date.available2025-09-07T07:18:13Z-
dc.date.issued2025-
dc.identifier.urihttp://repository.aaup.edu/jspui/handle/123456789/3545-
dc.descriptionMaster \ Immunohematologyen_US
dc.description.abstractBackground: Chronic myeloid leukemia (CML) is classified as a myeloproliferative neoplasm connected to the Philadelphia chromosome. This connection arises from the BCR-ABL fusion gene, resulting from a chromosome translocation between chromosomes 9 and 22. The gene BCR-ABL produces a continuous form of tyrosine kinase, which contributes to the progression of leukemia. There are various transcript variants, with E13a2 (B2a2) and E14a2 (B3a2) being the most prevalent. These variants are linked to specific diseases, their treatment outcomes, and general prognosis. Objectives: Our goal was to evaluate the connection between BCR-ABL transcript variants and various blood parameters (such as WBC, Hb, platelet count) in Palestinian patients diagnosed with CML, alongside their clinic pathological characteristics. Methodology: A cross-sectional sample of fifty patients with CML was selected from An-Najah National University Hospital in Palestine for this study. RNA was extracted from peripheral venous blood collected in EDTA tubes, and the variants of BCR-ABL transcripts were verified using RT-PCR. Additionally, data from the patients' medical records were gathered. Statistical analysis was used to examine the connection between the different transcript variants and various clinical and demographic factors. Results: The ratio of males to females was 1.27:1. Among the patients, twenty-nine had the b3a2 transcript, while twenty-one tested positives for the b2a2 variant. The total leukocyte count was higher in the b3a2 group compared to the b2a2 group, but the b2a2 variant had notably higher platelet counts than those with the b3a2 transcript. Conclusion: Our study showed a significant difference in blood-related measurements between b3a2 and b2a2 in CML, particularly regarding white blood cell and platelet counts. The variation in transcript expression linked to age might also suggest biological differences. These findings support the importance of transcript typing for diagnosing and predicting outcomes in CML, providing a useful reference for future studies within the Palestinian community.en_US
dc.publisherAAUPen_US
dc.subjectChronic Myeloid Leukemia (CML), BCR-ABL Transcript Variants, Philadelphia Chromosome, Hematological Parameters, Palestinian Patientsen_US
dc.titleCorrelation of Breakpoint Cluster Region - Abelson Murine Leukemia (BCR-ABL) transcript variants with hematological parameters and demographic characteristics in Palestinian patients with chronic myeloid leukemia رسالة ماجستيرen_US
dc.title.alternativeاختلافات النسخ بي سي ار اي بي ال ومعلمات الدم المختلفة والخصائص الديموغرافية لدى المرضي الفلسطينيين الذين يعانون من سرطان الدم النخاعي المزمن.en_US
dc.typeThesisen_US
Appears in Collections:Master Theses and Ph.D. Dissertations

Files in This Item:
File Description SizeFormat 
محمد قلالوة.pdf2.4 MBAdobe PDFThumbnail
View/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Admin Tools